Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback